Capitalizing on Asia as a source of growth and innovation for pharmas to narrow the gap in their pipelines, by Mr Enders Ekblom 2 February 2012 / By Valerie Lim / Clinical Trials, Partnering & Investment / 0 comments
Customizing your global regulatory strategy for efficient drug development, by Dr Joseph Scheeren, #Bayer Healthcare 31 January 2012 / By Valerie Lim / Clinical Trials / 0 comments
Global Trends, Opportunities, Challenge and Forecasts in Clinical Trial Management Systems 31 January 2012 / By YuenLing / Clinical Trials / 0 comments
Lambda Therapeutic Research Ltd @ BioPharma Asia Convention 2012 31 January 2012 / By YuenLing / Clinical Trials / 0 comments
Sanofi and Novartis pull out of bidding war for Illumina 31 January 2012 / By reneetan / Clinical Trials, Partnering & Investment, Supply Chain & Manufacturing / 0 comments
Preclinical safety analysis of innovative drugs: Determining clinical safety in preclinical studies, by Dr Steward Geary, #Eisai 31 January 2012 / By Valerie Lim / Clinical Trials / 1 comment
Leveraging on innovative strategies to achieve improved toxicology results and enhance the preclinical development cycle 31 January 2012 / By Valerie Lim / Clinical Trials / 0 comments
Accelerating regulatory approvals for clinical trials in Asia 31 January 2012 / By Valerie Lim / Clinical Trials / 0 comments
Developing an innovative preclinical model to drive R&D productivity, by Dr Haiyan Jiang 30 January 2012 / By Valerie Lim / Clinical Trials / 0 comments
Panel: Optimising clinical trials in Asian powerhouses – India & China 30 January 2012 / By Valerie Lim / Clinical Trials / 0 comments
